Sanofi Expense From Share-based Payment Transactions With Employees
Sanofi (SNY) reported Expense From Share-based Payment Transactions With Employees of EUR 245.00 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-02-24.
Discontinued › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2023-02-24
| Period end | Expense From Share-based Payment Transactions With Employees 12 month |
|---|---|
| 2022-12-31 | 245.00M EUR 20-F · filed 2023-02-24 |
| 2021-12-31 | 244.00M EUR 20-F · filed 2023-02-24 |
| 2020-12-31 | 274.00M EUR 20-F · filed 2023-02-24 |
| 2019-12-31 | 252.00M EUR 20-F · filed 2022-02-23 |
| 2018-12-31 | 282.00M EUR 20-F · filed 2021-03-04 |
| 2017-12-31 | 258.00M EUR 20-F · filed 2020-03-05 |
| 2016-12-31 | 250.00M EUR 20-F · filed 2019-03-08 |
| 2015-12-31 | 206.00M EUR 20-F/A · filed 2018-03-16 |